Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Starting retirement planning at 60 can present unique challenges. Learn how to effectively navigate this stage for a secure future.
20,891 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...
A fresh look at history shows disciplined buyers beat market timers over lengthy, stagnant periods. The counterintuit...
Four mega-cap stocks are emerging as the most-watched potential split candidates after notable 2026 moves. ASML, GE V...
A GOP lawmaker is proposing language to widen a congressional stock ban bill to cover prediction markets like Kalshi ...
A tidal wave of data centers is pushing power demands higher. Five dividend stocks are quietly funding the grid expan...
Chrysler is recalling over a million Jeep Wrangler and Gladiator models due to a fire risk when the vehicles are park...
XRP led gains in a choppy week, yet traders say ripple’s (xrp) breakout isn’t real until it clears the critical ceili...
"forget magnificent seven. this" is a line gaining traction as an equal-weight S&P 500 fund outperforms the cap-weigh...
A leading UK think tank highlights a counterintuitive risk: banning crypto privacy tools would not stop crypto activi...
A single quarterly beat isn’t the whole story. Micron’s latest results point to a multi-decade growth thesis that goe...
Two sentences: The oscars’ best picture category doubles as a market signal this year. Production data show shoots mo...